Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generation Bio
Biotech
Generation Bio eliminates 40% of staff, including C-suite execs
The layoffs will see Generation Bio’s chief development and medical officers exit the building and extend its runway into the second half of 2027.
Nick Paul Taylor
Nov 29, 2023 8:58am
Moderna pays Generation Bio $76M in lipid nanoparticle collab
Mar 23, 2023 10:58am
Generation Bio shares halved on hemophilia gene therapy setback
Dec 14, 2021 2:30pm
Next-gen gene therapies for rare diseases forge ahead
Dec 14, 2020 5:28am
Cell and gene therapy in the time of COVID-19: report
Aug 6, 2020 9:00am
Generation Bio tees up $125M IPO to push next-gen gene therapies
May 26, 2020 10:45am
